Reuters Health Information: Endoscopic ultrasound accurately detects bile duct stones
Endoscopic ultrasound accurately detects bile duct stones
Last Updated: 2017-07-05
By Reuters Staff
NEW YORK (Reuters Health) - Endoscopic ultrasound (EUS) is
somewhat more accurate than magnetic resonance
cholangiopancreatography (MRCP) for diagnosing
choledocholithiasis, researchers from Canada report.
EUS and MRCP are more accurate than clinical assessment and
abdominal ultrasound for diagnosing suspected
choledocholithiasis, but it is unclear whether one outperforms
the other in terms of diagnostic accuracy.
Dr. Mohammad Yaghoobi and colleagues from McMaster
University, Hamilton, Ontario, compared the diagnostic accuracy,
sensitivity, and specificity of EUS and MRCP in diagnosing
choledocholithiasis in their meta-analysis of five head-to-head
prospective studies involving a total of 272 patients.
The overall diagnostic accuracy of EUS was significantly
higher than that of MRCP, mainly due to significantly higher
sensitivity of EUS (97%) compared with MRCP (87%), according to
the June 20th Gastrointestinal Endoscopy online report.
Specificity was similar for EUS (90%) and MRCP (92%).
The two techniques did not differ in Youden�s index, a
general index of test accuracy that uses a combination of
sensitivity and specificity.
"Both EUS and MRCP are operative-dependent and the
interpretation of findings and subjective bias," the researchers
note. "However, the observed superiority in the sensitivity of
EUS as compared with MRCP might be due to better accuracy of EUS
in detection of small stones."
�EUS should be incorporated in the diagnostic algorithm in
patients suspected for choledocholithiasis, whenever
appropriate, given its reasonable safety profile,� they
conclude. �This might specially apply to the patients who need
an esophagogastroduodenoscopy for investigating other
alternative causes of abdominal pain. Future head-to-head
studies should focus on the size or clinical significance of the
choledocholithiasis identified by each modality.�
Dr. Yaghoobi did not respond to a request for comments.
SOURCE: http://bit.ly/2tD6dbS
Gastrointest Endosc 2017.
|